Jd. Safer et al., The thyroid hormone receptor-beta gene mutation R383H is associated with isolated central resistance to thyroid hormone, J CLIN END, 84(9), 1999, pp. 3099-3109
Resistance to thyroid hormone (RTH) action is due to mutations in the beta-
isoform of the thyroid hormone receptor (TR-beta). RTH patients display ina
ppropriate central secretion of TRH from the hypothalamus and of TSH from t
he anterior pituitary despite elevated levels of thyroid hormone (T-4 and T
-3). RTH mutations cluster in three hot spots in the C-terminal portion of
the TR-beta. Most individuals with TR-beta mutations have generalized resis
tance to thyroid hormone, where most tissues in the body are hyporesponsive
to thyroid hormone. The affected individuals are clinically euthyroid or e
ven hypothyroid depending on the severity of the mutation. Whether TR-beta
mutations cause a selective form of RTH that only leads to central thyroid
hormone resistance is debated. Here, we describe an individual with strikin
g peripheral sensitivity to graded T-3 administration. The subject was enro
lled in a protocol in which she received three escalating T-3 doses over a
13-day period. Indexes of central and peripheral thyroid hormone action wer
e measured at baseline and at each T-3 dose. Although the patient's resting
pulse rose only 11% in response to T-3, her serum ferritin, alanine aminot
ransferase, aspartate transaminase, and lactate dehydrogenase rose 320%, 11
7%, 121%, and 30%, respectively. In addition, her serum cholesterol, creati
nine phosphokinase, and deep tendon reflex relaxation time fell (25%, 36%,
and 36%, respectively). Centrally, the patient was sufficiently resistant t
o T-3 that her serum TSH was not suppressed with 200 mu g T-3, orally, dail
y for 4 days. The patient's C-terminal TR exons were sequenced revealing th
e mutation R383H in a region not otherwise known to harbor TR-beta mutation
s. Our clinical evaluation presented here represents the most thorough docu
mentation to date of the central thyroid hormone resistance phenotype in an
individual with an identified TR-beta mutation.